Specifically, data summarized here highlighted signaling pathways and processes related to a lung abnormal EC survival observed in PAH, including mediated by BMPR2 reduction and mutation, eNOS dysfunction, perivascular inflammation, and the role of infectious agents. Here, BMPR2 is linked to pulmonary arterial hypertension.